Soluble CD163 from activated macrophages predicts mortality in acute liver failure

Journal of Hepatology

Volumn 47, Issue 5, 2007, Pages 671-676

  Møller, Holger Jon ^a   Grønbæk, Henning ^a   Schiødt, Frank V ^b   Holland Fischer, Peter ^a   Schilsky, Michael ^c   Munoz, Santiago ^d   Hassanein, Tarek ^e   Lee, William M ^f  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Acute liver failure; Anti inflammatory markers; Prognostic score

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD163 ANTIGEN; CREATININE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERUM;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHEMOTAXIS, LEUKOCYTE; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; MACROPHAGES; MALE; MONITORING, IMMUNOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SURVIVAL RATE; UP-REGULATION;

EID: 34848840320     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.05.014     Document Type: Article

References (28)

1. Liu Z.X., and Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2 (2006) 493-503
2. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., and Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 32 (2000) 734-739
3. Antoniades C.G., Berry P.A., Davies E.T., Hussain M., Bernal W., Vergani D., et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44 (2006) 34-43
4. Nagaki M., Iwai H., Naiki T., Ohnishi H., Muto Y., and Moriwaki H. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis. J Infect Dis 182 (2000) 1103-1108
5. Moestrup S.K., and Møller H.J. CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 36 (2004) 347-354
6. Hiraoka A., Horiike N., Akbar S.M., Michitaka K., Matsuyama T., and Onji M. Expression of CD163 in the liver of patients with viral hepatitis. Pathol Res Pract 201 (2005) 379-384
7. Hiraoka A., Horiike N., Akbar S.M., Michitaka K., Matsuyama T., and Onji M. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 40 (2005) 52-56
8. Jalan R. Gc-Globulin to predict outcome in acute liver failure: a panacea?. Liver Transpl 11 (2005) 1169-1171
9. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. U.S. Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
10. Møller H.J., Hald K., and Moestrup S.K. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 62 (2002) 293-299
11. O'Grady J.G., Alexander G.J., Hayllar K.M., and Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445
12. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 73 (2003) 209-212
13. Buechler C., Ritter M., Orso E., Langmann T., Klucken J., and Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67 (2000) 97-103
14. Sulahian T.H., Hogger P., Wahner A.E., Wardwell K., Goulding N.J., Sorg C., et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12 (2000) 1312-1321
15. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., et al. Identification of the haemoglobin scavenger receptor. Nature 409 (2001) 198-201
16. Maniecki M.B., Møller H.J., Moestrup S.K., and Møller B.K. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 211 (2006) 407-417
17. Droste A., Sorg C., and Hogger P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 256 (1999) 110-113
18. Weaver L.K., Hintz-Goldstein K.A., Pioli P.A., Wardwell K., Qureshi N., Vogel S.N., et al. Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 80 (2006) 26-35
19. Schaer D.J., Schleiffenbaum B., Kurrer M., Imhof A., Bachli E., Fehr J., et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 74 (2005) 6-10
20. Møller H.J., Moestrup S.K., Weis N., Wejse C., Nielsen H., Pedersen S.S., et al. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med 34 (2006) 2561-2566
21. Møller H.J., Peterslund N.A., Graversen J.H., and Moestrup S.K. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 99 (2002) 378-380
22. Møller H.J., de Fost M., Aerts H., Hollak C., and Moestrup S.K. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol 72 (2004) 135-139
23. Edwards J.P., Zhang X., Frauwirth K.A., and Mosser D.M. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 80 (2006) 1298-1307
24. Porcheray F., Viaud S., Rimaniol A.C., Leone C., Samah B., Dereuddre-Bosquet N., et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142 (2005) 481-489
25. Emmenegger U., Schaer D.J., Larroche C., and Neftel K.A. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 135 (2005) 299-314
26. Schaer D.J., Schaer C.A., Schoedon G., Imhof A., and Kurrer M.O. Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur J Haematol 77 (2006) 432-436
27. Davis B.H., and Zarev P.V. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 63 (2005) 16-22
28. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36